| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 12,338 | 6,169 | 0 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ANGEL OAK MULTI-STRATEGY INCOME FUND CLASS INSTL | 45,159 | 37,768 |
| VIRTUS NEWFLEET MULTI-SECTOR SHORT TERM BOND FUND CLASS I | 40,081 | 38,121 |
| ISHARES 20+ YEAR TREAS BOND ETF | 38,650 | 38,421 |
| ISHARES CORE U.S. AGGREGATE BOND ETF | 119,070 | 114,606 |
| WISDOMTREE FLOATING RATE TREASURY ETF | 94,848 | 94,671 |
| AMERICAN BEACON TWENTYFOUR STRAT INC FUND CLASS Y | 82,530 | 76,505 |
| COHEN & STEERS LOW DURATION PREF & INC FUND CLASS I | 38,915 | 37,859 |
| GUGGENHEIM MACRO OPPORTUNITIES FUND CLASS INSTITUTIONAL | 80,018 | 76,302 |
| LORD ABBETT BOND DEBENTURE FUND CLASS F | 119,259 | 114,711 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| JPM STRAT INCOME OPPORT FD SEL #3844 | 48,690 | 48,819 |
| JPM VALUE ADV FD SEL #1399 | 638,077 | 849,402 |
| REVELIS BIOECLIPSE SPV II LLC | 339,500 | 350,000 |
| MORGAN STANLEY FINANCE T-GEARS INTL BASKET | 500,000 | 685,600 |
| APL GROUP CORP COM STK | 969,053 | 7,450,076 |
| HSBC USA INC L/O SDT-AN NDX RTY SPX | 400,000 | 364,000 |
| GS FINANCE CORP L/O SDT-AN INDU MXEF | 200,000 | 174,400 |
| HSBC USA INC L/O SDT-AN RTY SPX | 200,000 | 205,200 |
| MORGAN STANLEY FINANCE L/O SDT-AN EFA IWM SPY | 600,000 | 582,900 |
| JP MORGAN SDT-AN MXEF SX5E | 300,000 | 272,100 |
| MORGAN STANELY FINANCE L/O SDT-AN NDX RTY | 166,670 | 158,420 |
| GS FINANCE CORP L/O SDT-AN MXEA RTY SPX | 400,000 | 353,200 |
| BOFA FINANCE LLC L/O SDT-AN RTY SPX SX5E | 150,000 | 141,300 |
| BOFA FINANCE LLC L/O SDT-AN MXEF SX5E | 150,000 | 129,450 |
| CITIGROUP GLOBAL MARKETS L/O SDT-AN IWN RSP | 200,000 | 199,800 |
| MORGAN STANLEY FINANCE L/O SDT-AN NDX SX5E | 200,000 | 179,100 |
| CREDIT SUISSE AG L/O SDT-AN EEM IWM | 200,000 | 160,600 |
| ROYAL BANK OF CANADA T-GEARS INTL BASKET | 200,000 | 182,800 |
| ROYAL BANK OF CANADA CT-GEARS MXEF | 120,000 | 91,320 |
| CITIGROUP GLOBAL MARKETS L/O SDT-AN MXEF SPX | 333,330 | 283,664 |
| CITIGROUP GLOBAL MARKETS L/O SDT-AN MXEF SPX | 200,000 | 179,200 |
| HSBC USA INC L/O SDT-AN INDU RTY SPX | 300,000 | 301,800 |
| JP MORGAN CHASE FINANCIAL L/O SDT-AN INDU NDX RTY | 260,000 | 236,080 |
| MORGAN STANLEY FINANCE L/O SDT-AN INDU NDX RTY | 180,000 | 157,590 |
| CREDIT SUISSE AG LONDON L/O SDT-AN RTY SPX | 240,000 | 203,040 |
| MORGAN STANLEY FINANCE T-SS SPX | 200,000 | 185,100 |
| MORGAN STANLEY FINANCE L/O SDT-AN RTY SPX | 300,000 | 307,650 |
| ISHARES RUSSELL 1000 ETF | 551,456 | 543,727 |
| ISHARES RUSSELL 1000 VALUE ETF | 307,148 | 308,600 |
| ISHARES RUSSELL 1000 GROWTH ETF | 201,758 | 195,392 |
| ISHARES S&P MID-CAP 400 VALUE ETF | 167,842 | 173,346 |
| ISHARES S&P MID-CAP 400 GROWTH ETF | 132,447 | 135,704 |
| ISHARES S&P SMALL-CAP 600 VALUE ETF | 94,700 | 96,050 |
| ISHARES S&P SMALL CAP 600 GROWTH ETF | 56,600 | 58,097 |
| VANGUARD FTSE DEVELOPED MKT ETF | 535,764 | 525,261 |
| AMERICAN CENTURY EMERGING MARKET FUND CLASS I | 169,019 | 159,156 |
| FRANKLIN INTL GROWTH FUND ADVISOR | 171,304 | 166,852 |
| LAZARD EMERGING MARKETS FUND INSTITUTIONAL SHS | 166,484 | 159,776 |
| LAZARD GLOBAL LISTED INFRAS PORT INSTL FUND | 54,015 | 57,831 |
| MANNING & NAPIER FUND INC. RAINIER INTL DISCOVERY SERIES FD CL I | 73,044 | 69,419 |
| VIRTUS KAR EMERGING MARKETS SMALL CAP FUND CLASS I | 83,322 | 78,561 |
| WESTWOOD SALIENT MLP & ENERGY INFRASTRUCTURE FUND INSTITUTIONAL | 117,017 | 118,309 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ABBEY CAPITAL FUTURES STRATEGY FUND CLASS I | AT COST | 73,097 | 75,029 |
| JP MORGAN OPPORTUNISTIC EQUITY L/S FUND CLASS I | AT COST | 81,266 | 75,794 |
| 361 GLOBAL LONG SHORT EQUITY FUND CLASS I | AT COST | 79,868 | 77,746 |
| FS CHIRON CAPITAL ALLOCATION FUND CLASS I | AT COST | 101,958 | 98,005 |
| AGL CLO EQUITY FUND, LP | AT COST | 438,678 | 438,678 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| PROMISSORY NOTE (BIOECLIPSE THERAPEUTICS, INC.) | 0 | 250,000 | 250,000 |
| Description | Amount |
|---|---|
| OTHER CHANGES IN NET ASSETS | 832 |
| REDUCTION IN VALUE OF DONATED APPRECIATED STOCK | 8,857,237 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT MANAGEMENT FEES | 41,692 | 41,692 | 0 | |
| BANK FEES | 0 | 0 | 0 | |
| K-1 LOSS - REVELIS BIOECLIPSE SPV II LLC, A SERIES | 1,494 | 1,494 | 0 |
| Name | Address |
|---|---|
| IAN ASHKEN |
500 SOUTH POINTE DRIVE 240 MIAMI BEACH,FL33139 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| NYS FILING FEES | 750 | 0 | 0 | |
| FEDERAL EXCISE TAXES | 16,718 | 0 | 0 |